TMO Thermo Fisher Scientific Inc.

Five-factor quant read, peer ranking, and the analyst team's own call.

5.1
composite/ 10
Value computed
2.3

priced for 13.0% growth vs -0.3% delivered · -52% to base-case fair value

Quality computed
6.3

Piotroski 4/8 · Altman safe zone · ROE 13% · interest covered 6x

Momentum rank
3.0

strong 3-month run · beating the S&P over 3 months

Defensive rank
9.0
Tactical rank
5.0

Descriptive, not predictive. Momentum, Defensive and Tactical are deciles within our liquid universe; Value and Quality are computed from filed financials. None of them forecasts a return - the model's out-of-sample AUC is published in the whitepaper. Deciles as of 2026-09-02.

Peer comparison

Composite score against sector peers · 6 names

#1
8.6
#2
7.3
#3
7.1
#4
5.4
#5
5.1
#6
4.5

TMO ranks #5 of 6 · peer average 6.3

No current desk call on TMO. The factor scores above are computed; a full analysis is four analyst desks, a bull-vs-bear debate and a risk committee, and takes about three minutes.

Automated, educational research - not investment advice, and not a recommendation to buy or sell any security.